US Broker Ratings

Dyne Therapeutics (DYN) Stock Analysis: Exploring a 42.86% Upside in the Biotechnology Sector

Investors with a keen eye on the biotechnology sector should pay close attention to Dyne Therapeutics, Inc. (NASDAQ: DYN), a clinical-stage company focused on revolutionizing treatments for neuromuscular diseases. With..

Mesoblast Limited (MESO) Stock Analysis: Exploring a Promising 109% Potential Upside

Mesoblast Limited (NASDAQ: MESO), a prominent player in the biotechnology sector, is capturing investor attention with its impressive potential upside of 109.46%. Trading at $16.71, the stock’s average target price..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Navigating Growth with a Unique Market Position and Analyst Confidence

Guardian Pharmacy Services, Inc. (NYSE: GRDN), a prominent player in the healthcare sector, specifically within the medical care facilities industry, has been making waves with its innovative approach to serving..

GoodRx Holdings, Inc. (GDRX) Investor Outlook: Analyzing a 42.86% Potential Upside in the Healthcare Sector

GoodRx Holdings, Inc. (NASDAQ: GDRX) stands at a unique crossroads in the healthcare sector, offering individual investors an intriguing blend of risk and reward. With its market capitalization currently sitting..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring a 35% Upside Potential in the Healthcare Sector

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) is a dynamic player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a current market capitalization of $1.12 billion,..

Disc Medicine, Inc. (IRON) Stock Analysis: A 20% Upside Potential in the Biotech Sector

Disc Medicine, Inc. (NASDAQ: IRON), a dynamic player in the biotechnology sector, has caught the attention of investors with its robust product pipeline and promising financial outlook. Headquartered in Watertown,..

Evotec SE (EVO) Stock Analysis: Navigating a Potential 32.76% Upside in the Healthcare Sector

Evotec SE (EVO), a prominent player in the healthcare sector, is currently drawing significant attention from investors keen on its potential upside. With its stock price hovering at $4.12 USD..

Evolent Health, Inc (EVH) Stock Analysis: A 102% Potential Upside Amidst Healthcare Sector Challenges

Evolent Health, Inc. (NYSE: EVH) is a compelling player within the healthcare sector, specifically in the niche of health information services. With a market capitalization of $886.02 million, Evolent Health..

Novavax, Inc. (NVAX) Stock Analysis: Unpacking a 51.85% Upside Potential and the Road Ahead

Novavax, Inc. (NASDAQ: NVAX) is a name that continues to draw considerable attention within the biotechnology sector, particularly for investors eyeing significant potential upside. With a market capitalization of $1.41..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: A Closer Look at the 21.95% Potential Upside

Amneal Pharmaceuticals, Inc. (AMRX), a global biopharmaceutical company, has been capturing investor attention, not only for its diverse range of pharmaceutical products but also for its significant potential upside. Currently..

Viridian Therapeutics, Inc. (VRDN) Stock Analysis: Exploring a 69.70% Potential Upside in the Biotechnology Sector

Viridian Therapeutics, Inc. (VRDN), a prominent player in the biotechnology sector, has been making waves with its innovative approach to developing treatments for serious and rare diseases. With a current..

Opko Health, Inc. (OPK): Analyst Ratings Shine with 150% Potential Upside Amidst Current Challenges

Opko Health, Inc. (OPK), a prominent player in the healthcare sector, is drawing significant attention from investors, especially with its analyst ratings projecting a striking 150% potential upside. Despite facing..

CONMED Corporation (CNMD) Stock Analysis: Unveiling a 28.8% Potential Upside in the Medical Device Sector

CONMED Corporation (NASDAQ: CNMD), a distinguished player in the medical devices industry, presents an intriguing opportunity for investors with its substantial 28.8% potential upside. Headquartered in Largo, Florida, and boasting..

Schrodinger, Inc. (SDGR): Analyst Ratings Reveal a 21.79% Upside Potential

Investors looking to capitalize on innovation in healthcare technology should take a closer look at Schrodinger, Inc. (NASDAQ: SDGR). With a market capitalization of $1.63 billion, this New York-based company..

U.S. Physical Therapy, Inc. (USPH) Investor Outlook: Exploring a 17.58% Potential Upside

Savvy investors seeking promising opportunities in the healthcare sector should take a closer look at U.S. Physical Therapy, Inc. (NYSE: USPH). With its solid footing in the medical care facilities..

BioLife Solutions, Inc. (BLFS) Stock Analysis: A 12.34% Upside Potential in the Booming Cell and Gene Therapy Market

BioLife Solutions, Inc. (NASDAQ: BLFS) is a name that continues to attract attention in the healthcare sector, particularly within the niche of medical instruments and supplies. With a market cap..

Arcutis Biotherapeutics, Inc. (ARQT)

⚠️ No article content returned.

..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Exploring a 63% Potential Upside for Investors

LifeStance Health Group, Inc. (NASDAQ: LFST) is a prominent player in the healthcare sector, specifically within the medical care facilities industry, focusing on providing outpatient mental health services across the..

Ultragenyx Pharmaceutical Inc. (RARE): Investor Outlook with 143% Potential Upside

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) is capturing the attention of investors, especially those with an appetite for the dynamic and transformative biotech sector. With a market capitalization of $3.4 billion,..

Zai Lab Limited (ZLAB) Stock Analysis: A Biotech Contender with 109% Upside Potential

Zai Lab Limited (NASDAQ: ZLAB), the Chinese biopharmaceutical powerhouse, is making waves in the biotechnology sector with a robust portfolio of products and strategic collaborations. With a market capitalization of..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds